Immune Checkpoint Inhibitors in the Treatment of Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Immune Checkpoint Inhibitors in the Treatment of Renal Cell Carcinoma

Published:2020-01 Issue:1 Volume:40 Page:76-85
ISSN:0270-9295
Container-title:Seminars in Nephrology
language:en
Short-container-title:Seminars in Nephrology

Author:

Parikh Mamta,Bajwa Poornima

Publisher

Elsevier BV

Subject

Nephrology

Reference48 articles.

1. A phase II study of surveillance in patients with metastatic renal cell carcinoma and assessment of response of such patients to therapy on progression;Oliver;Mol Biother,1988

2. Unexplained spontaneous regression and alpha interferon as treatment for metastatic renal cell carcinoma;Oliver;Br J Urol,1989

3. Spontaneous regression of histologically proved pulmonary metastases from renal cell carcinoma: a case with 5-year followup;Vogelzang;J Urol,1992

4. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma;Motzer;J Clin Oncol,2002

5. Duration of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response;Rosenberg;Ann Surg,1998

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The gut microbiome and dietary metabolites in the treatment of renal cell carcinoma;Urologic Oncology: Seminars and Original Investigations;2024-08

2. Immunotherapy of Clear-Cell Renal-Cell Carcinoma;Cancers;2024-05-31

3. 15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysis;eClinicalMedicine;2024-02

4. Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort;European Journal of Cancer;2024-01

5. Real-World Treatment Patterns and Effectiveness of Patients With Advanced Renal Cell Carcinoma: A Nationwide Observational Study;Clinical Genitourinary Cancer;2023-11